Conditions & Outcomes
Six areas of focus. Each one backed by the compounds in our formulas — with the studies to match.
Joints & Connective Tissue
BPC-157 Arginate is currently under investigation in a randomized human trial at the University of Zagreb (NCT07437547) for its role in connective tissue repair and joint recovery.
The science →
Gut Barrier & Digestion
Zinc-L-Carnosine has been studied for its effect on intestinal permeability. In controlled studies, it reduced gut permeability markers by 70% within 14 days.
The science →
Inflammation & Discomfort
PEA (Palmitoylethanolamide) has been studied across 1,196 patients for its role in modulating discomfort via PPAR-alpha pathways. Up to 35% reduction in discomfort scores reported in month one.
The science →
Sleep & Nervous System
Nervous-system recovery and the parasympathetic shift required for deep restorative sleep are supported by the peptide system.
"Sleep tracking went from 24% to 72% over four weeks. The difference is felt, not just measured." — G. Johnny, 4 weeksThe science →
Collagen & Elasticity
BPC-157 Arginate and TB4-derived fragment have been studied in preclinical models for their role in collagen synthesis, angiogenesis (VEGF), and connective tissue remodeling.
in animal studies
The science →
Daily Baseline
Consistency drives outcomes. Members who stay on protocol report compounding improvements across mobility, gut, and energy. Average time on protocol: 6 months.
"Six months in, it's the most consistent part of my routine." — S. Adler, 24 weeksStart the protocol →
